Top Institute Pharma (TIP)-glucocorticoids research University Medical Centre Utrect (UMCU) rheumatology: cardiovascular risk factors and insulin resistancy in rheumatoid arthritis patients with and without glucocorticoids
| ISRCTN | ISRCTN53261020 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN53261020 |
| Secondary identifying numbers | NTR1028 |
- Submission date
- 23/08/2007
- Registration date
- 23/08/2007
- Last edited
- 17/10/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Jos N. Hoes
Scientific
Scientific
University Medical Centre Utrecht
Department of Rheumatology and Clinical Immunology, F02.127
Utrecht
3584 RD
Netherlands
| Phone | +31 (0)30 250 5240 |
|---|---|
| mail@hoesjn.org |
Study information
| Study design | Observational clinical trial |
|---|---|
| Primary study design | Observational |
| Secondary study design | Single-centre |
| Study setting(s) | Hospital |
| Study type | Diagnostic |
| Scientific title | |
| Study acronym | TIP-GC-UMCU |
| Study objectives | What is the relation between disease activity, treatment, and metabolic syndrome/insulin resistance? |
| Ethics approval(s) | Ethics approval pending from the METC UMC-Utrecht (The Netherlands) as of 31st August 2007. |
| Health condition(s) or problem(s) studied | Insulin resistancy in rheumatoid arthritis patients |
| Intervention | 1. Oral glucose tolerance test (OGTT) 2. X-rays of hand, feet, lungs and spinal cord 3. Electrocardiogram (ECG) |
| Intervention type | Other |
| Primary outcome measure | 1. Metabolic syndrome/insulin resistance 2. Disease (RA) activity Timepoints will be measured during a one time visit of the patient (duration approximately four hours). |
| Secondary outcome measures | No secondary outcome measures |
| Overall study start date | 01/10/2007 |
| Completion date | 01/10/2010 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | 300 |
| Key inclusion criteria | Diagnosis rheumatoid arthritis with disease duration greater than two years |
| Key exclusion criteria | Does not comply with the above inclusion criteria |
| Date of first enrolment | 01/10/2007 |
| Date of final enrolment | 01/10/2010 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
University Medical Centre Utrecht
Utrecht
3584 RD
Netherlands
3584 RD
Netherlands
Sponsor information
University Medical Centre Utrecht (UMCU) (The Netherlands)
Hospital/treatment centre
Hospital/treatment centre
Department of Rheumatology and Clinical Immunology
P.O. Box 85500
Utrecht
3508 GA
Netherlands
| Website | http://www.umcutrecht.nl/zorg/ |
|---|---|
"ROR" |
https://ror.org/04pp8hn57 |
Funders
Funder type
Industry
Top Institute Pharma (TIPharma) (The Netherlands)
Private sector organisation / Other non-profit organizations
Private sector organisation / Other non-profit organizations
- Alternative name(s)
- TI Pharma
- Location
- Netherlands
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
